Breaking News Instant updates and real-time market news.

ANTM

Anthem

$215.98

-0.89 (-0.41%)

, CNC

Centene

$93.28

0.13 (0.14%)

06:59
11/10/17
11/10
06:59
11/10/17
06:59

Insurers see early surge in sign-ups for ACA, WSJ reports

Early sign-ups and traffic for the open-enrollment period of the Affordable Care Act has been seemingly strong with over 600,000 people choosing plans via the federal HealthCare.gov website in the first four days, the Wall Street Journal reports, citing insurers. Insurers Highmark Health, CareSource, Independence Blue Cross and Sanford Health Plan said so far they have experienced significantly increased sign-ups compared to last year but warned its too early to predict how final enrollment numbers will fare. Publicly traded companies in the space include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG). Reference Link

ANTM

Anthem

$215.98

-0.89 (-0.41%)

CNC

Centene

$93.28

0.13 (0.14%)

HUM

Humana

$247.46

3.98 (1.63%)

MOH

Molina Healthcare

$76.60

0.04 (0.05%)

WCG

WellCare

$200.66

-2.19 (-1.08%)

CI

Cigna

$197.52

-2.98 (-1.49%)

HNT

Health Net

AET

Aetna

$172.53

-2.91 (-1.66%)

UNH

UnitedHealth

$211.56

0.79 (0.37%)

  • 28

    Nov

ANTM Anthem
$215.98

-0.89 (-0.41%)

11/07/17
LEER
11/07/17
NO CHANGE
Target $300
LEER
Outperform
Anthem price target raised to $300 from $245 at Leerink
Leerink analyst Ana Gupte raised her price target for Anthem to $300 from $245 as she sees the appointment of Gail Boudreaux as its next CEO as a "strong driver" of multiple expansion. The analyst reiterates an Outperform rating on the shares.
10/30/17
LEER
10/30/17
NO CHANGE
LEER
Leerink sees CVS/Aetna as primarily a defensive play
Leerink analyst Ana Gupte sees CVS Health (CVS)-Aetna (AET) as primarily a defensive, not offensive play to fight dual threats of Captive PBMs and Amazon (AMZN) and for Aetna, a response to Optum, Anthem (ANTM) IngenioRx and growth challenges. The analyst expects bio-pharma cost savings for consumers unlikely to improve, with potential loss of health plan business while efficiencies in the specialty pharmacy supply chain through Home Health are not enhanced. Anti-trust approval is possible, but likely challenged by the loss of health plan clients such as Anthem that reduce buying power, Gupte contends, adding that she sees Humana (HUM) merging with Express Scripts (ESRX) and WellCare (WCG) or Humana by Cigna (CI) as the most likely near-term.
11/03/17
FBCO
11/03/17
INITIATION
Target $234
FBCO
Outperform
Anthem initiated with an Outperform at Credit Suisse
Credit Suisse analyst A.J. Rice started Anthem with an Outperform rating and $234 price target.
11/09/17
BARD
11/09/17
NO CHANGE
Target $101
BARD
Outperform
Anthem significantly opens access to Sarepta DMD drug, says Baird
Baird analyst Brian Skorney noted that Anthem (ANTM) has reversed course with its new coverage policy for Sarepta's (SRPT) Duchenne muscular dystrophy drug Exondys 51, as the insurer now considers the drug "medically necessary," compared to its prior view of eteplirsen as "investigational and not medically necessary." This is a significant step in the right direction for Sarepta and points to continued progress on the reimbursement front, Skorney tells investors. He maintains an Outperform rating and $101 price target on Sarepta shares.
CNC Centene
$93.28

0.13 (0.14%)

10/17/17
BMOC
10/17/17
INITIATION
Target $120
BMOC
Outperform
Centene initiated with an Outperform at BMO Capital
BMO Capital analyst Matt Borsch initiated Centene with an Outperform rating and a price target of $120. Borsch cites attractive sector-relative valuation as well as multi-year growth expectations with revenue opportunity above $500B as high-acuity Medicaid populations are brought into managed care.
11/03/17
FBCO
11/03/17
INITIATION
Target $102
FBCO
Neutral
Centene initiated with a Neutral at Credit Suisse
Credit Suisse analyst A.J. Rice started Centene with a Neutral rating and $102 price target.
10/25/17
OPCO
10/25/17
NO CHANGE
Target $111
OPCO
Outperform
Centene price target raised to $111 from $105 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for Centene to $111 from $105 following quarterly results. The analyst reiterates an Outperform rating on the shares.
10/16/17
LEER
10/16/17
NO CHANGE
LEER
Facilities, Centene most structurally impacted to downside in 2019, says Leerink
Leerink analyst Ana Gupte sees the Facilities and Centene (CNC) most structurally impacted to the downside in 2019 and beyond at 15% of earnings, if there is no legislative or other budgetary compromise to restore the Cost Sharing Subsidies after President Trump's executive action to stop funding them. The analyst also notes that Healthcare Facilities also face a structural headwind in 2019 and beyond with Exchanges contributing 1%-5% of EBITDA. In the near-term in 2017, Gupte says Molina Healthcare (MOH) faces transient balance sheet pressure with the Q4 unfunding placing pressure of $135M and wiping excess parent cash possibly necessitating an equity raise, while other HIX plans Anthem (ANTM), Centene and Cigna (CI) can offset with their excess capitalization at the subsidiaries and at the parent.
HUM Humana
$247.46

3.98 (1.63%)

10/13/17
LEER
10/13/17
NO CHANGE
LEER
Ending of ACA subsidies most negative for Centene, says Leerink
Leerink analyst Ana Gupte says the shutting off of the cost sharing subsidies on Affordable Care Act exchanges is most negative for Centene (CNC). The company is "highly profitable" on the exchanges at 15% of earnings, Gupte tells investors in a research note. Molina Healthcare (MOH) and Anthem (ANTM) are exposed on the top line but are losing money, the analyst adds. She notes that UnitedHealth (UNH), Humana (HUM) and Aetna (AET) have exited the exchanges while WellCare (WCG) has not been on them. Centene in premarket trading is down 6% to $88.00 while Molina is down 3% to $61.50.
10/16/17
BMOC
10/16/17
INITIATION
Target $300
BMOC
Outperform
Humana initiated with an Outperform at BMO Capital
BMO Capital analyst Matt Borsch initiated Humana with an Outperform and $300 price target saying it is the only "pure play" Medicare name in the sector, which is the most attractive growth area in a growth oriented industry.
11/03/17
FBCO
11/03/17
INITIATION
Target $256
FBCO
Neutral
Humana initiated with a Neutral at Credit Suisse
Credit Suisse analyst A.J. Rice started Humana with a Neutral rating and $256 price target.
MOH Molina Healthcare
$76.60

0.04 (0.05%)

10/23/17
WOLF
10/23/17
UPGRADE
WOLF
Outperform
Molina Healthcare upgraded to Outperform from Peer Perform at Wolfe Research
10/16/17
BMOC
10/16/17
INITIATION
Target $70
BMOC
Market Perform
Molina Healthcare initiated with a Market Perform at BMO Capital
BMO Capital analyst Matt Borsch initiated LifePoint with an Market Perform and $70 price target due to lack of visibility and until there is more clarity on the scope of the profitability impairment.
10/16/17
PIPR
10/16/17
NO CHANGE
PIPR
Piper a buyer of Centene, Molina after Friday's selloff
Piper Jaffray analyst Sarah James believes Friday's selloff in shares of Centene (CNC) and Molina Healthcare (MOH) caused by President Trump's executive actions is overdone. Both companies are well positioned to handle the Affordable Care Act changes given their focus on lower income/higher subsidy exchange members, James tells investors in a research note. She sees Centene and Molina as less vulnerable to adverse selection risk and is a buyer of both names.
WCG WellCare
$200.66

-2.19 (-1.08%)

11/01/17
WELS
11/01/17
NO CHANGE
Target $188
WELS
Market Perform
WellCare price target raised to $188 from $175 at Wells Fargo
Wells Fargo analyst Peter Costa raised his price target for WellCare to $188 from $175 as its Q3 adjusted EPS far exceeded expectations. The analyst reiterates a Market Perform rating on the shares.
11/01/17
PIPR
11/01/17
NO CHANGE
Target $214
PIPR
Overweight
WellCare price target raised to $214 from $199 at Piper Jaffray
Piper Jaffray analyst Sarah James raised her price target for WellCare to $214 saying she'd still be a buyer of the stock post yesterday's rally. The analyst believes 2018 could top consensus expectations and keeps an Overweight rating on the stock.
10/16/17
BMOC
10/16/17
INITIATION
Target $215
BMOC
Outperform
WellCare initiated with an Outperform at BMO Capital
BMO Capital analyst Matt Borsch initiated WellCare with an Outperform and $215 price target due to its product, market position at the intersection of Medicaid and Medicare, the significant room we see for margin expansion, and relatively "modest" size.
CI Cigna
$197.52

-2.98 (-1.49%)

11/03/17
FBCO
11/03/17
INITIATION
Target $219
FBCO
Outperform
Cigna initiated with an Outperform at Credit Suisse
Credit Suisse analyst A.J. Rice started Cigna with an Outperform rating and $219 price target.
10/16/17
BMOC
10/16/17
INITIATION
Target $210
BMOC
Market Perform
Cigna initiated with a Market Perform at BMO Capital
BMO Capital analyst Matt Borsch initiated Cigna with an Market Perform and $210 price target due to its slower-growth commercial mix.Target $210.
HNT Health Net

06/23/17
JEFF
06/23/17
NO CHANGE
JEFF
Jefferies says healthcare rally 'appropriate' after 'toothless' AHCA rewrite
Jefferies analyst David Windley said the rally yesterday in healthcare stocks was appropriate given the "anemic" rewrite of the AHCA healthcare bill by Senate Republicans. The key changes are removal of "pay-for" taxes, a somewhat longer runway for Exchange cost-sharing reduction subsidies, and delayed Medicaid transition to per capita caps, he tells investors. Windley called Cigna (CI) "probably the safest MCO in this noise", adding that Humana (HUM) would benefit most from the proposed removal of the health insurer fee. Other publicly traded healthcare insurers include Aetna (AET), Anthem (ANTM), Centene (CNC), Health Net (HNT), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
10/02/17
BERN
10/02/17
NO CHANGE
BERN
Bernstein does not anticipate ACA fix/repeal before 2018 election
While noting the resignation of Health Secretary Tom Price, Bernstein analyst Lance Wilkes says he does not anticipate an Affordable Care act fix or ACA repeal before the 2018 election. The analyst expects tax reform will "suck the oxygen out of the room" until close to the election. A fix for 2019 is possible, but faces the headwind of the 2018 election campaign, he contends, adding that he believes CSR funding could be included in a trade for the upcoming budget and the Health Insurance Fee could be suspended as part of tax reform, but both are not highly likely at this point. Publicly traded companies in the space include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
AET Aetna
$172.53

-2.91 (-1.66%)

11/03/17
RAJA
11/03/17
UPGRADE
Target $200
RAJA
Outperform
Aetna upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst Michael Baker upgraded Aetna (AET) to Outperform and established a $200 price target saying risk/reward is skewed to the upside in light of a potential acquisition by CVS (CVS) for over $200 per share. Baker likes the potential combination telling investors it would create the next generation of health benefit manager combining scaled medical and pharmacy capabilities and repositioning retail to more health care centric, lower cost care, and with additional health insurance options.
11/07/17
JEFF
11/07/17
NO CHANGE
Target $76
JEFF
Buy
Jefferies not seeing multiple expansion for CVS until concerns dissipate
While the stock has come down significantly, overhangs on CVS Health will likely prevent meaningful share upside in the near-term, Jefferies analyst Brian Tanquilut tells investors in a post-earnings research note. He lowered his price target for the shares to $76 from $86 following the company's Q3 results and keeps a Hold rating on the name. Investors seem focused on a potential acquisition of Aetna (AET) and continued risk from Amazon.com (AMZN), Tanquilut contends. He believes these two concerns needs to dissipate before CVS Health's multiple expands.
11/03/17
FBCO
11/03/17
INITIATION
Target $174
FBCO
Neutral
Aetna initiated with a Neutral at Credit Suisse
Credit Suisse analyst A.J. Rice started Aetna with a Neutral rating and $174 price target.
UNH UnitedHealth
$211.56

0.79 (0.37%)

11/06/17
WBLR
11/06/17
NO CHANGE
WBLR
Outperform
Tivity Health selloff today a buying opportunity, says William Blair
William Blair views today's pullback in shares of Tivity Health (TVTY) as overdone and recommends buying the shares at current levels. While the news from UnitedHealth (UNH) represents lost contracts, management has been aware of this since June, the firm tells investors. It notes Tivity successfully extended its contract with UnitedHealth this year.
11/06/17
OPCO
11/06/17
NO CHANGE
OPCO
Tivity Health oversold on UnitedHealth news, says Oppenheimer
Oppenheimer analyst Mohan Naidu views Tivity Health (TVTY) as oversold after UnitedHealth (UNH) said its Optum Fitness Advantage program will be available, at no additional cost, to Individual Medicare Advantage plans members in 11 states, starting January 2018. The analyst believes this is only for the individual market and that Tivity's SilverSneakers will be available for all group members. Further, he notes that Tivity management confirmed that their initial 2018 guidance already contemplates the impact of the UnitedHealth rollout. While it is possible that the Optum Fitness introduction is a precursor to a broader program, SilverSneaker's name and trust drives a lot of enrollment decisions and will likely be a deciding factor in the expansion of this new offering, Naidu tells investors in an intraday research note. Tivity Health is down 31%, or $14.70, to $33.35 in afternoon trading.
11/06/17
JEFF
11/06/17
NO CHANGE
JEFF
Buy
Tivity Health should be bought on selloff, says Jefferies
Jefferies analyst David Styblo estimates Tivity Health's (TVTY) contract with UnitedHealth (UNH) represents 15% of Tivity's revenue and today's pullback on news of a competitor to Silver Sneakers seems to be pricing in "more than a worst case scenario." He would be a buyer on the selloff.
11/07/17
BRRR
11/07/17
NO CHANGE
Target $40
BRRR
Outperform
Tivity Health price target lowered to $40 from $46 at Barrington
Barrington analyst Michael Petusky lowered his price target for Tivity Health (TVTY) to $40 after UnitedHealth (UNH), which represents about 15%-17% of Tivity's overall revenue, disclosed that it would be competing with the company's SilverSneakers program in 11 states as of January 1, 2018. Based on the analyst's conversation last night with management, he still suspects UnitedHealth will continue to be a material customer of Tivity through at least the end of the contract in 2020. Petusky cations, however, that he has no real clarity on how much additional business could transition to United's internal offering beyond 2018. He maintains an Outperform rating on Tivity Health.

TODAY'S FREE FLY STORIES

TWX

Time Warner

$88.72

0.71 (0.81%)

, GE

General Electric

$18.21

-0.04 (-0.22%)

20:02
11/19/17
11/19
20:02
11/19/17
20:02
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

TWX

Time Warner

$88.72

0.71 (0.81%)

GE

General Electric

$18.21

-0.04 (-0.22%)

IBM

IBM

$148.97

-0.15 (-0.10%)

BHGE

Baker Hughes

$30.91

0.76 (2.52%)

HMC

Honda

$32.62

0.02 (0.06%)

GLPG

Galapagos NV

$90.83

-0.66 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 14

    Dec

BABA

Alibaba

$185.13

-0.3 (-0.16%)

18:01
11/19/17
11/19
18:01
11/19/17
18:01
Hot Stocks
Alibaba, Auchan Retail, Ruentex form new retail strategic alliance »

Alibaba, Auchan Retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$88.72

0.71 (0.81%)

, CMCSA

Comcast

$36.16

-0.91 (-2.45%)

17:32
11/19/17
11/19
17:32
11/19/17
17:32
Hot Stocks
Box Office Battle: 'Justice League' wins weekend with just $96M »

Warner Bros.' (TWX)…

TWX

Time Warner

$88.72

0.71 (0.81%)

CMCSA

Comcast

$36.16

-0.91 (-2.45%)

CMCSK

Comcast

SNE

Sony

$46.17

0.07 (0.15%)

FOX

21st Century Fox

$30.48

1.88 (6.57%)

FOXA

21st Century Fox

$31.15

1.83 (6.24%)

LGF.A

Lionsgate

$32.59

1.55 (4.99%)

DIS

Disney

$103.44

-0.16 (-0.15%)

VIAB

Viacom

$26.15

2.46 (10.38%)

VIA

Viacom

$33.00

2.9 (9.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.04 (-0.22%)

17:10
11/19/17
11/19
17:10
11/19/17
17:10
Periodicals
GE yet to decide which directors will lose seats, WSJ reports »

A housecleaning at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLPG

Galapagos NV

$90.83

-0.66 (-0.72%)

17:01
11/19/17
11/19
17:01
11/19/17
17:01
Hot Stocks
Galapagos NV reports positive topline results from ALBATROSS with GLPG2222 »

Galapagos NV reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$262.26

-1.44 (-0.55%)

16:55
11/19/17
11/19
16:55
11/19/17
16:55
Hot Stocks
Boeing, Avolon finalize deal for 75 737 MAX airplanes »

Boeing and Avolon have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBLK

Star Bulk Carriers

$9.60

0.19 (2.02%)

16:53
11/19/17
11/19
16:53
11/19/17
16:53
Earnings
Star Bulk Carriers reports Q3 adjusted EPS (8c), consensus (5c) »

"We released today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 28

    Nov

BDRBF

Bombardier

$2.43

0.0007 (0.03%)

16:22
11/19/17
11/19
16:22
11/19/17
16:22
Hot Stocks
Bombardier predicts Latin America's 60-150 seat aircraft fleet will double »

Bombardier Commercial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

TSLA

Tesla

$315.05

2.55 (0.82%)

10:21
11/18/17
11/18
10:21
11/18/17
10:21
Periodicals
Tesla new super car to cost $200,000, Recode says »

Alongside its new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 16

    Jan

GT

Goodyear Tire

$29.94

0.63 (2.15%)

10:17
11/18/17
11/18
10:17
11/18/17
10:17
Hot Stocks
Goodyear Tire, NASCAR extend relationship »

NASCAR and Goodyear Tire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Jan

  • 16

    Jan

HMC

Honda

$32.62

0.02 (0.06%)

10:05
11/18/17
11/18
10:05
11/18/17
10:05
Periodicals
Honda recalls 900,000 minivans on tip forward seats, Reuters says »

Honda Motor is recalling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$88.43

-0.82 (-0.92%)

09:48
11/18/17
11/18
09:48
11/18/17
09:48
Periodicals
Activist investors Nelson Peltz still in P&G picture, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHGE

Baker Hughes

$30.91

0.76 (2.52%)

, GE

General Electric

$18.21

-0.04 (-0.22%)

09:39
11/18/17
11/18
09:39
11/18/17
09:39
Periodicals
Buy Baker Hughes, Barron's says »

While it is "not…

BHGE

Baker Hughes

$30.91

0.76 (2.52%)

GE

General Electric

$18.21

-0.04 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

CSCO

Cisco

$35.90

0.02 (0.06%)

09:19
11/18/17
11/18
09:19
11/18/17
09:19
Periodicals
More needed for Cisco to have 'groove back,' Barron's says »

While the Nasdaq…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 11

    Dec

  • 17

    Jan

  • 17

    Jan

IBM

IBM

$148.97

-0.15 (-0.10%)

09:10
11/18/17
11/18
09:10
11/18/17
09:10
Periodicals
IBM could be next to fetch higher valuation, Barron's says »

Investors are warming to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

GE

General Electric

$18.21

-0.04 (-0.22%)

09:05
11/18/17
11/18
09:05
11/18/17
09:05
Periodicals
Option play offer some help given GE dividend, depressed stock, Barron's says »

While wagering against…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.04 (-0.22%)

09:00
11/18/17
11/18
09:00
11/18/17
09:00
Periodicals
Risk remains after GE dividend cut, Barron's says »

While buying General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$88.72

0.71 (0.81%)

, T

AT&T

$34.51

-0.01 (-0.03%)

08:21
11/18/17
11/18
08:21
11/18/17
08:21
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

TWX

Time Warner

$88.72

0.71 (0.81%)

T

AT&T

$34.51

-0.01 (-0.03%)

NYT

New York Times

$17.65

0.05 (0.28%)

TEX

Terex

$44.82

0.8 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

TPIC

TPI Composites

$19.06

-0.97 (-4.84%)

07:25
11/18/17
11/18
07:25
11/18/17
07:25
Conference/Events
TPI Composites to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SYNA

Synaptics

$38.21

0.57 (1.51%)

04:55
11/18/17
11/18
04:55
11/18/17
04:55
Conference/Events
Synaptics management to meet with KeyBanc »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 06

    Dec

WGL

WGL Holdings

$84.32

-0.14 (-0.17%)

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Earnings
WGL Holdings reports Q4 adjusted EPS (17c), consensus (19c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

, LMOS

Lumos Networks

17:58
11/17/17
11/17
17:58
11/17/17
17:58
Hot Stocks
Tactile Systems to replace Lumos Networks in S&P 600 at open on 11/22 »

EQT Infrastructure…

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

, MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

17:56
11/17/17
11/17
17:56
11/17/17
17:56
Hot Stocks
Breaking Hot Stocks news story on Invesco Mortgage, MKS Instruments »

Invesco Mortgage to…

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

17:55
11/17/17
11/17
17:55
11/17/17
17:55
Hot Stocks
MKS Instruments to replace Brocade in S&P 400 at open on 11/22 »

S&P 500 constituent…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.